Suivre
Michael Dürr
Michael Dürr
Faculty Member Nephrology, Charité Universtitätsmedizin
Adresse e-mail validée de charite.de
Titre
Citée par
Citée par
Année
A unique population of IgG-expressing plasma cells lacking CD19 is enriched in human bone marrow
HE Mei, I Wirries, D Frölich, M Brisslert, C Giesecke, JR Grün, T Alexander, ...
Blood, The Journal of the American Society of Hematology 125 (11), 1739-1748, 2015
1682015
Preemptive treatment of Cytomegalovirus infection in kidney transplant recipients with letermovir: results of a Phase 2a study
S Stoelben, W Arns, L Renders, J Hummel, A Mühlfeld, M Stangl, ...
Transplant International 27 (1), 77-86, 2014
1422014
The need for minimization strategies: current problems of immunosuppression
J Bamoulid, O Staeck, F Halleck, D Khadzhynov, S Brakemeier, M Dürr, ...
Transplant International 28 (8), 891-900, 2015
1262015
Increased incidence of angioedema with ACE inhibitors in combination with mTOR inhibitors in kidney transplant recipients
M Duerr, P Glander, F Diekmann, D Dragun, HH Neumayer, K Budde
Clinical Journal of the American Society of Nephrology 5 (4), 703-708, 2010
882010
COVID-19 pandemic and worldwide organ transplantation: a population-based study
O Aubert, D Yoo, D Zielinski, E Cozzi, M Cardillo, M Dürr, ...
The Lancet Public Health 6 (10), e709-e719, 2021
842021
A randomized clinical trial of anti–IL-6 antibody clazakizumab in late antibody-mediated kidney transplant rejection
K Doberer, M Duerr, PF Halloran, F Eskandary, K Budde, H Regele, ...
Journal of the American Society of Nephrology 32 (3), 708-722, 2021
822021
Experience with belatacept rescue therapy in kidney transplant recipients
S Brakemeier, D Kannenkeril, M Dürr, T Braun, F Bachmann, D Schmidt, ...
Transplant International 29 (11), 1184-1195, 2016
572016
In vivo haematopoietic activity is induced in neurosphere cells by chromatin‐modifying agents
C Schmittwolf, N Kirchhof, A Jauch, M Dürr, F Harder, M Zenke, AM Müller
The EMBO Journal 24 (3), 554-566, 2005
572005
Review of bortezomib treatment of antibody-mediated rejection in renal transplantation
NS Ejaz, RR Alloway, F Halleck, M Dürr, K Budde, ES Woodle
Antioxidants & redox signaling 21 (17), 2401-2418, 2014
532014
Clazakizumab in late antibody-mediated rejection: study protocol of a randomized controlled pilot trial
F Eskandary, M Dürr, K Budde, K Doberer, R Reindl-Schwaighofer, ...
Trials 20 (1), 1-13, 2019
502019
Multifrequency magnetic resonance elastography for the assessment of renal allograft function
SRM Garcia, T Fischer, M Dürr, E Gültekin, J Braun, I Sack, J Guo
Investigative Radiology 51 (9), 591-595, 2016
462016
Assessment of the kidney donor profile index in a European cohort
LJ Lehner, A Kleinsteuber, F Halleck, D Khadzhynov, E Schrezenmeier, ...
Nephrology Dialysis Transplantation 33 (8), 1465-1472, 2018
442018
Dendritic cell–regulatory T‐cell interactions control self‐directed immunity
C Lange, M Dürr, H Doster, A Melms, F Bischof
Immunology and cell biology 85 (8), 575-581, 2007
442007
Conversion to belatacept in maintenance kidney transplant patients: a retrospective multicenter European study
A Darres, C Ulloa, S Brakemeier, C Garrouste, O Bestard, A Del Bello, ...
Transplantation 102 (9), 1545-1552, 2018
422018
Enteric-coated mycophenolate sodium
K Budde, M Dürr, L Liefeldt, HH Neumayer, P Glander
Expert opinion on drug safety 9 (6), 981-994, 2010
422010
Biomarkers of over‐immunosuppression
K Budde, M Matz, M Dürr, P Glander
Clinical Pharmacology & Therapeutics 90 (2), 316-322, 2011
392011
A preliminary reconstruction of the Proto-Mixtec tonal system
M Dürr
Indiana 11, 19-61, 1990
391990
Exploring the complexity of death-censored kidney allograft failure
M Mayrdorfer, L Liefeldt, K Wu, B Rudolph, Q Zhang, F Friedersdorff, ...
Journal of the American Society of Nephrology 32 (6), 1513-1526, 2021
382021
An evaluation of sirolimus in renal transplantation
F Halleck, M Duerr, J Waiser, L Huber, M Matz, S Brakemeier, L Liefeldt, ...
Expert opinion on drug metabolism & toxicology 8 (10), 1337-1356, 2012
382012
Identification and therapeutic management of highly sensitized patients undergoing renal transplantation
L Huber, N Lachmann, M Dürr, M Matz, L Liefeldt, HH Neumayer, ...
Drugs 72, 1335-1354, 2012
382012
Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.
Articles 1–20